Carbapenem-resistant Klebsiella pneumoniae infections in a Greek intensive care unit: Molecular characterisation and treatment challenges

Journal of Global Antimicrobial Resistance

Volumn 3, Issue 2, 2015, Pages 123-127

  Katsiari, Maria ^a   Panagiota, Giakkoupi ^b   Likousi, Sophia ^a   Roussou, Zoi ^a   Polemis, Michalis ^c   Alkiviadis Vatopoulos, C ^b,c   Evangelia Platsouka, D ^a   Maguina, Asimina ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^c Department of Epidemiological Surveillance and Intervention   (Greece)

Author keywords

Carbapenemase producing Klebsiella pneumoniae; Infection control bundle; Molecular typing; Mortality; Treatment regimens

Indexed keywords

CARBAPENEMASE; COLISTIN; IMIPENEM; TIGECYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; GREECE; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MOLECULAR TYPING; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE;

EID: 84947026350     PISSN: 22137165     EISSN: 22137173     Source Type: Journal    
DOI: 10.1016/j.jgar.2015.01.006     Document Type: Article

References (15)

1. Greek system for the surveillance of antimicrobial resistance 2014 http://www.mednet.gr/whonet [accessed 30.04.14]
2. O. Zarkotou, S. Pournaras, P. Tselioti, V. Dragoumanos, V. Pitiriga, K. Ranellou, and et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment Clin Microbiol Infect 17 2011 1798 1803
3. G. Patel, S. Huprikar, S.H. Factor, S.G. Jenkins, and D.P. Calfee Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies Infect Control Hosp Epidemiol 29 2008 1099 1106
4. T.C. Horan, M. Andrus, and M.A. Dudeck CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332
5. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. Document M100-S22 2012 CLSI Wayne, PA
6. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0 2014 http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-tables/Breakpoint-table-v-4.0.pdf [accessed 05.02.15]
7. A. Tsakris, A. Poulou, S. Pournaras, E. Voulgari, G. Vrioni, K. Themeli-Digalaki, and et al. A simple phenotypic method for the differentiation of metallo-β-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates J Antimicrob Chemother 65 2010 1664 1671
8. C.C. Papagiannitsis, K. Tryfinopoulou, P. Giakkoupi, O. Pappa, M. Polemis, E. Tzelepi, and et al. Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals Int J Antimicrob Agents 39 2012 178 180
9. P. Giakkoupi, H. Maltezou, M. Polemis, O. Pappa, G. Saroglou, and A.C. Vatopoulos Greek system for the surveillance of antimicrobial resistance. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone Euro Surveill 14 pii 2009 19218
10. H. Grundmann, D.M. Livermore, C.G. Giske, R. Canton, G.M. Rossolini, J. Campos, et al. CNSE Working Group Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts Euro Surveill 15 pii 2010 19711
11. E.A. Neuner, J.Y. Yeh, G.S. Hall, J. Sekeres, A. Endimiani, R.A. Bonomo, and et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections Diagn Microbiol Infect Dis 69 2011 357 362
12. K. Pontikis, I. Karaiskos, S. Bastani, G. Dimopoulos, M. Kalogirou, M. Katsiari, and et al. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria Int J Antimicrob Agents 43 2014 52 59
13. S. Pournaras, G. Vrioni, E. Neou, J. Dendrinos, E. Dimitroulia, A. Poulou, and et al. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay Int J Antimicrob Agents 37 2011 244 247
14. M. Tumbarello, P. Viale, C. Viscoli, E.M. Trecarichi, F. Tumietto, A. Marchese, and et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy Clin Infect Dis 55 2012 943 950
15. G.L. Daikos, S. Tsaousi, L.S. Tzouvelekis, I. Anyfantis, M. Psichogiou, A. Argyropoulou, and et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems Antimicrob Agents Chemother 58 2014 2322 2328